ClexBio
PrivateLast Round
Seed
Nov 22, 2024
Total Funding Raised
$2.2M
Company Overview
ClexBio is a biotechnology company that develops next-generation engineered tissue therapeutics to address chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ClexBio Comparables
Compare ClexBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AIM Biotech | 84% | |
| Beonchip | 83% | |
| AlveoliX AG | 81% |
ClexBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 22, 2024 | ||||
| Seed | Jul 20, 2021 | ||||
| Grant | Jul 20, 2021 |
Key People
Founding team and executive leadership
ClexBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Foundation | Seed |
| EPSRC | Grant |
| Innovasjon Norge | Grant |
| GG1978 | Seed |
| The Research Council of Norway | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 22, 2024
Raised capital from GG1978 and EQT Foundation.
- Oct 29, 2024
Monthly visitors grew 476% MoM, from 79 to 455.
ClexBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ClexBio's valuation, stock price, and market status.
Is ClexBio a public or private company?
ClexBio is a private company.
What is the current stock price of ClexBio?
ClexBio is a private company with no public stock price. Caplight tracks ClexBio's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is ClexBio worth (valuation)?
Valuation information for ClexBio is not publicly available.
Can I buy ClexBio stock?
ClexBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ClexBio's last funding round?
ClexBio's most recent funding round was Seed on November 22, 2024.
Who are the main investors in ClexBio?
Key investors in ClexBio include EQT Foundation, EPSRC, Innovasjon Norge, GG1978, The Research Council of Norway.
Will ClexBio IPO soon?
No public IPO plans have been announced for ClexBio.
How can I track ClexBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ClexBio's secondary market activity and sign up for updates.